Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Hepatogastroenterology ; 47(31): 165-7, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-10690603

RESUMO

The association between venous thromboembolism and cancer has been widely documented and the main factor responsible for cancer-induced venous thromboembolism is considered mostly linked to a hypercoagulation state induced by the cancer itself. There is no consensus on investigative strategies for occult cancer in a patient with a thrombophilic condition. We report a patient who manifested an isolated episode of pulmonary embolism without specific evident sources of venous thromboembolism. The routine clinical and laboratory work-up to detect an occult cancer did not reveal any malignancy. A history of duodenal ulcer in association with a recent slight alteration in bowel habits led us to perform an esophagogastroduodenoscopy which was negative for malignancy, and a barium enema followed by colonoscopy, which revealed the presence of a tumor limited to the large intestine. An unexplained clinically evident hypercoagulation state, even in the presence of mild clinical symptoms, needs more thorough diagnostic strategies when simple methods of screening for occult cancer are negative.


Assuntos
Adenocarcinoma/complicações , Neoplasias do Colo/complicações , Embolia Pulmonar/etiologia , Adenocarcinoma/diagnóstico , Idoso , Neoplasias do Colo/diagnóstico , Humanos , Masculino
2.
Dig Dis Sci ; 36(9): 1204-8, 1991 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-1893805

RESUMO

The effect of short-term oral zinc supplementation (zinc sulfate 600 mg/day) on hepatic encephalopathy, was assessed in a double-blind, crossover trial. Fifteen cirrhotic patients with stable, chronic hepatic encephalopathy were randomized to receive either oral zinc or a placebo for 10 days. Following a two-week washout period, these were crossed over to the alternate treatment. Conn's index, which comprises the evaluation of the mental state, asterixis, number connection test, EEG record, and plasma ammonia, was used to score the degree of hepatic encephalopathy, both at the beginning and end of each treatment period. Serum zinc was significantly raised after oral zinc administration and reached the levels observed in cirrhotics without hepatic encephalopathy. Despite this, however, no modification in the parameters included in Conn's index were observed. In conclusion, this study failed to confirm that short-term oral zinc supplementation improves chronic hepatic encephalopathy.


Assuntos
Encefalopatia Hepática/tratamento farmacológico , Sulfatos/uso terapêutico , Zinco/uso terapêutico , Administração Oral , Idoso , Método Duplo-Cego , Feminino , Encefalopatia Hepática/etiologia , Humanos , Cirrose Hepática/complicações , Masculino , Pessoa de Meia-Idade , Sulfatos/administração & dosagem , Fatores de Tempo , Zinco/administração & dosagem , Sulfato de Zinco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA